Story

Czech Current Account Swings to Wider-Than-Expected Deficit in May

ENTHMSVIIDZHZH-TWJAKOHI
Jul 14, 20261 min read
Czech Current Account Swings to Wider-Than-Expected Deficit in May

Summary

The Czech Republic's current account balance recorded a 38.31 billion crown deficit in May, reversing an April surplus and exceeding analyst forecasts, according to central bank data.

Text size
Background

The Czech Republic's current account balance unexpectedly swung to a deficit of 38.31 billion crowns ($1.80 billion) in May, a sharp reversal from the previous month's surplus. The figure, released Tuesday by the country's central bank, was significantly larger than the 25.00 billion crown shortfall anticipated by analysts in a Reuters poll.

Deficit Details

The May deficit marks a significant shift from the revised 1.18 billion crown surplus recorded in April. However, on a year-over-year basis, the country's external position showed improvement, with the deficit narrowing from the 64.23 billion crown shortfall registered in May of the prior year.

The balance of goods and services, a key component of the current account, posted a surplus of 35.91 billion crowns. This was an increase from April's 28.01 billion crown surplus but remained below the 50.74 billion crown surplus seen in the same month a year earlier.

Financial Flows

Sample IUX Markets – In-articleAd

The financial account, which tracks the movement of investment capital, recorded a deficit of 11.98 billion crowns. This contrasted with a surplus of 24.66 billion crowns in April. A breakdown of the financial account includes:

  • Direct investment: Stood at 7.75 billion crowns, a notable decrease from 24.95 billion crowns in the previous month.
  • Portfolio investment: Reached 0.95 billion crowns.
  • Reserve assets: Declined by 21.86 billion crowns during the month.

The wider-than-expected current account deficit provides a new data point for investors assessing the Czech economy's external balances and could influence sentiment around the Czech koruna.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST